???????? ?????? ???????? ?????????????????? (????????) ?????? ???? ?????? ?????????????? ???????? ???? ????????????????????

???????? ?????? ???????? ?????????????????? (????????) ?????? ???? ?????? ?????????????? ???????? ???? ????????????????????

Cell and gene therapy-based products have the potential to be a viable and disease-modifying treatment for diseases that would otherwise be incurable with conventional medicines.

Get Your Samples - https://bit.ly/3FkGWGo

Cell and gene therapies (CGTs) are at the cutting edge of technology in the treatment of both severe and uncommon illnesses. LUXTURNA, a therapy for a hereditary retinal illness that causes blindness, is one of several such medicines presently on the market.

Key players operating in the global Market?-

Smith+Nephew

NuVasive

百时美施贵宝

Kolon TissueGene, Inc.

JCR Pharmaceuticals

Cells for Cells

#healthcareit #healthcaretechnology #healthcareresearch #marketresearch #marketing #business #research #digitalmarketing #marketingstrategy #branding #market #entrepreneur #covid #survey #dataanalytics #data #insights #marketanalysis #healthcare #surveys #datacollection #entrepreneurship #paidsurveys #customerexperience #leadgeneration #dataanalysis #businessstrategy

要查看或添加评论,请登录

Sarthak Joshi的更多文章

社区洞察

其他会员也浏览了